Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Ipca Laboratories

Ipca Laboratories

BSE: 524494|NSE: IPCALAB|ISIN: INE571A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 16:00
1092.25
-11.9 (-1.08%)
VOLUME 5,021
LIVE
NSE
Dec 06, 15:57
1091.10
-14.15 (-1.28%)
VOLUME 127,441
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Nine Months of Ipca Laboratories

------------------- in Rs. Cr. -------------------
Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Net Sales/Income from operations 2,799.34 2,436.46 2,405.27 2,159.55 2,437.20
Other Operating Income -- -- 48.68 29.23 20.01
Total Income From Operations 2,799.34 2,436.46 2,453.95 2,188.78 2,457.21
EXPENDITURE
Consumption of Raw Materials 831.88 699.66 715.64 706.40 880.75
Purchase of Traded Goods 123.83 125.22 120.86 102.20 88.24
Increase/Decrease in Stocks -64.93 31.61 39.05 20.29 -82.79
Power & Fuel -- -- -- -- --
Employees Cost 575.42 544.22 516.19 454.12 410.82
Depreciation 130.27 131.21 128.22 116.85 119.51
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 814.64 704.00 695.28 652.13 673.36
P/L Before Other Inc. , Int., Excpt. Items & Tax 388.23 200.54 238.71 136.79 367.32
Other Income 40.01 28.15 16.99 16.09 21.44
P/L Before Int., Excpt. Items & Tax 428.24 228.69 255.70 152.88 388.76
Interest 12.24 17.57 23.20 57.10 37.86
P/L Before Exceptional Items & Tax 416.00 211.12 232.50 95.78 350.90
Exceptional Items -- -- -- -- 2.26
P/L Before Tax 416.00 211.12 232.50 95.78 353.16
Tax 70.56 29.32 88.60 36.20 104.84
P/L After Tax from Ordinary Activities 345.44 181.80 143.90 59.58 248.32
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 345.44 181.80 143.90 59.58 248.32
Equity Share Capital 25.27 25.24 25.24 25.24 25.24
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 27.34 14.41 11.40 4.72 19.68
Diluted EPS 27.34 14.41 11.40 4.72 19.68
EPS After Extra Ordinary
Basic EPS 27.34 14.41 11.40 4.72 19.68
Diluted EPS 27.34 14.41 11.40 4.72 19.68
Public Share Holding
No Of Shares (Crores) -- -- -- -- 6.83
Share Holding (%) -- -- -- -- 54.11
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- 0.12
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 2.14
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 0.98
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- 5.67
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 97.86
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 44.91
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for ipcalaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.